Prostate cancer incidence, clinical stage and survival in relation to obesity: A prospective cohort study in Denmark

No abstract is available for this paper.

• Publication year

  2015

• Venue

  International Journal of Cancer

• Publication date

  2015-04-15

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1002/ijc.29238PMID 25264293
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dissecting the association between metabolic syndrome and prostate cancer risk: analysis of a large clinical cohort.

  2015cited by this paper
• Obesity and prostate cancer: weighing the evidence.

  2013cited by this paper
• Modification of the association between obesity and lethal prostate cancer by TMPRSS2:ERG.

  2013cited by this paper
• Micronutrient intake and risk of prostate cancer in a cohort of middle-aged, Danish men

  2013influential reference
• The fat side of prostate cancer.

  2013cited by this paper
• Prostate cancer in Denmark 1978–2009 — trends in incidence and mortality

  2013cited by this paper
• Baseline prostate-specific antigen measurements and subsequent prostate cancer risk in the Danish Diet, Cancer and Health cohort.

  2013cited by this paper
• Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort

  2012cited by this paper
• Prospective study on metabolic factors and risk of prostate cancer

  2012cited by this paper
• Obesity, body composition, and prostate cancer

  2012cited by this paper
• The correlation between metabolic syndrome and prostatic diseases.

  2012cited by this paper
• Body mass index and incidence of localized and advanced prostate cancer--a dose-response meta-analysis of prospective studies.

  2012cited by this paper
• Weight change and prostate cancer incidence and mortality

  2012cited by this paper
• Lifestyle and dietary factors in the prevention of lethal prostate cancer.

  2012cited by this paper
• Metabolic alterations and targeted therapies in prostate cancer

  2011cited by this paper
• The association of weight gain during adulthood with prostate cancer incidence and survival: A population‐based cohort

  2011cited by this paper
• Body mass index in early and middle-late adulthood and risk of localised, advanced and fatal prostate cancer: a population-based prospective study

  2011cited by this paper
• Intake of whole-grain products and risk of prostate cancer among men in the Danish Diet, Cancer and Health cohort study

  2011cited by this paper
• Body Mass Index, Prostate Cancer–Specific Mortality, and Biochemical Recurrence: a Systematic Review and Meta-analysis

  2011cited by this paper
• Body composition and body fat distribution in relation to later risk of acute myocardial infarction: a Danish follow-up study

  2011cited by this paper
• Predictive value of digital rectal examination for prostate cancer detection is modified by obesity

  2011cited by this paper
• The metabolic syndrome and risk of prostate cancer in Italy.

  2011cited by this paper
• Associations between an Obesity Related Genetic Variant (FTO rs9939609) and Prostate Cancer Risk

  2010cited by this paper
• Fatty acid synthase polymorphisms, tumor expression, body mass index, prostate cancer risk, and survival.

  2010cited by this paper
• Blood pressure, body size and prostate cancer risk in the Swedish Construction Workers cohort

  2010cited by this paper
• Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growth.

  2008cited by this paper
• Body Size and Risk of Prostate Cancer in the European Prospective Investigation into Cancer and Nutrition

  2008cited by this paper
• General and abdominal adiposity and risk of death in Europe.

  2008cited by this paper
• Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer.

  2008cited by this paper
• Major shifts in the treatment and prognosis of prostate cancer due to changes in pathological diagnosis and grading

  2007cited by this paper
• Study design, exposure variables, and socioeconomic determinants of participation in Diet, Cancer and Health: A population-based prospective cohort study of 57,053 men and women in Denmark

  2007cited by this paper
• Androgens, lipogenesis and prostate cancer.

  2004cited by this paper
• Disassembly of Transcriptional Regulatory Complexes by Molecular Chaperones

  2002cited by this paper
• Molecular Identification of Cytosolic Prostaglandin E2 Synthase That Is Functionally Coupled with Cyclooxygenase-1 in Immediate Prostaglandin E2Biosynthesis*

  2000cited by this paper

• Obesogens in Prostate Cancer: An Endocrine and Metabolic Threat

  2026cites this paper
• Obesity-linked genes may promote prostate cancer among Asian and Hispanic immigrants to North America.

  2026cites this paper
• Association between visceral adiposity index and prostate cancer in men aged 40 years and older: a nationwide cross-sectional study

  2025cites this paper
• Assessing the relationship between cardiometabolic diseases and the risk of developing aggressive prostate cancer: a systematic review and meta-analysis

  2025cites this paper
• Tributyltin-dysregulated periprostatic adipose tissue enhances prostate cell survival and migration, implicating the C-C motif chemokine receptor 3

  2025cites this paper
• Role of body mass index and weight change in the risk of cancer: A systematic review and meta-analysis of 66 cohort studies

  2024cites this paper
• Exosomes That Have Different Cellular Origins Followed by the Impact They Have on Prostate Tumor Development in the Tumor Microenvironment

  2024cites this paper
• Mendelian randomization evidence based on European ancestry for the causal effects of leukocyte telomere length on prostate cancer

  2024cites this paper
• Association between adiposity after diagnosis of prostate cancer and mortality: systematic review and meta-analysis

  2023cites this paper
• Diabetes and prostate cancer, an ambiguous relationship between two pathologies of high worldwide prevalence

  2023cites this paper
• Obesity and prostate cancer — microenvironmental roles of adipose tissue

  2023cites this paper
• The Impact of Lifestyle on Prostate Cancer: A Road to the Discovery of New Biomarkers

  2022cites this paper
• Metabolism and cancer-select topics

  2022cites this paper
• Neighborhood Obesogenic Environment and Risk of Prostate Cancer: The Multiethnic Cohort.

  2022cites this paper
• The impact of body mass index on prostate cancer: An updated systematic review and meta-analysis

  2022cites this paper
• Circadian Rhythm Disruption as a Contributor to Racial Disparities in Prostate Cancer

  2022cites this paper
• Obesity-Related Cross-Talk between Prostate Cancer and Peripheral Fat: Potential Role of Exosomes

  2022cites this paper
• Adiposity and cancer survival: a systematic review and meta-analysis

  2022cites this paper
• Non‐alcoholic fatty liver disease increases the risk of biochemical recurrence in high‐grade metastatic prostate cancer patients

  2021cites this paper
• Association of Obesity With Survival Outcomes in Patients With Cancer

  2021cites this paper
• Waist circumference and a body shape index and prostate cancer risk and mortality

  2021cites this paper
• Obesity as a Risk Factor for Prostate Cancer Mortality: A Systematic Review and Dose-Response Meta-Analysis of 280,199 Patients

  2021cites this paper
• Factors Influencing Care Pathways for Breast and Prostate Cancer in a Hospital Setting

  2021influential citation
• Body Composition and Prostate Cancer Risk: A Systematic Review of Observational Studies.

  2021cites this paper
• Systematic review and meta-analysis of the associations between body mass index, prostate cancer, advanced prostate cancer, and prostate-specific antigen

  2020cites this paper
• An examination of the association between lifetime history of prostate and pancreatic cancer diagnosis and occupation in a population sample of Canadians

  2020cites this paper
• CILP2 overexpression correlates with tumor progression and predicts poor outcome in patients with colorectal cancer

  2020cites this paper
• CILP2 overexpression predicts poor prognosis in colorectal cancer

  2020cites this paper
• Prognostic Value of CT-Attenuation and 18F-Fluorodeoxyglucose Uptake of Periprostatic Adipose Tissue in Patients with Prostate Cancer

  2020cites this paper
• CILP2 overexpression correlates with tumor progression and poor prognosis in patients with colorectal cancer in The Cancer Genome Atlas (TCGA) study

  2020cites this paper
• Virtual Screening and Bioactivity Evaluation of Novel Androgen Receptor Antagonists From Anti-PCa Traditional Chinese Medicine Prescriptions

  2020cites this paper
• Leptin Promotes Prostate Cancer Proliferation and Migration by Stimulating STAT3 Pathway

  2020cites this paper
• Prostatakarzinom: Epidemiologie und Risikofaktoren

  2020cites this paper
• Obesity, race, and long‐term prostate cancer outcomes

  2020cites this paper
• Obesity paradox in patients with cancer: A systematic review and meta-analysis of 6,320,365 patients

  2020cites this paper
• Can the Irisin be a Biomarker for Prostate Cancer? A Case Control Study

  2020cites this paper
• Phthalate exposure and prostate cancer in a population-based nested case-control study.

  2019cites this paper
• Nutrition and Cancer

  2019cites this paper
• Systemic Treatment of Prostate Cancer in Elderly Patients: Current Role and Safety Considerations of Androgen-Targeting Strategies

  2019cites this paper
• Pre-diagnosis body mass index, physical activity and ovarian cancer mortality.

  2019cites this paper
• Systematic review and meta-analysis of the associations between body mass index, prostate cancer, advanced prostate cancer, and prostate-specific antigen

  2019cites this paper
• Serum glucose, triglycerides, and cholesterol in relation to prostate cancer death in the Swedish AMORIS study

  2018cites this paper
• BMI trajectories and risk of overall and grade‐specific prostate cancer: An observational cohort study among men seen for prostatic conditions

  2018cites this paper
• Clinical and biochemical markers of visceral adipose tissue activity: Body mass index, visceral adiposity index, leptin, adiponectin, and matrix metalloproteinase-3. Correlation with Gleason patterns 4 and 5 at prostate biopsy

  2018cites this paper
• Peri‐prostatic adipose tissue: the metabolic microenvironment of prostate cancer

  2018cites this paper
• Periprostatic fat tissue transcriptome reveals a signature diagnostic for high-risk prostate cancer.

  2018cites this paper
• Neoplasia in Patients with Excess Fat Mass

  2018cites this paper
• Heterogeneity in risk of prostate cancer: A Swedish population‐based cohort study of competing risks and Type 2 diabetes mellitus

  2018cites this paper
• Obese patients with castration‐resistant prostate cancer may be at a lower risk of all‐cause mortality: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database

  2018cites this paper
• A stage-dependent link between metabolic syndrome components and incident prostate cancer

  2018cites this paper
• No Association of Waist Circumference and Prostate Cancer in the Cancer Prevention Study II Nutrition Cohort

  2017cites this paper
• Long-term prediction of prostate cancer diagnosis and death using PSA and obesity related anthropometrics at early middle age: data from the malmö preventive project

  2017cites this paper
• Phase II Prospective Randomized Trial of Weight Loss Prior to Radical Prostatectomy (PCAN-17-0128)

  2017cites this paper
• PPARGC1A and ADIPOQ polymorphisms are associated with aggressive prostate cancer in Mexican-Mestizo men with overweight or obesity

  2017cites this paper
• Association of a TFAM haplotype with aggressive prostate cancer in overweight or obese Mexican Mestizo men.

  2017cites this paper
• Diet, Physical Activity, and Body Weight in Cancer Survivorship.

  2017cites this paper
• Body mass index and incidence of nonaggressive and aggressive prostate cancer: a dose-response meta-analysis of cohort studies

  2017cites this paper
• Obesity and prostate cancer

  2017cites this paper
• Nuclear magnetic resonance spectroscopy as a new approach for improvement of early diagnosis and risk stratification of prostate cancer

  2017influential citation
• PSA MASS DENSITY – A MEASURE PREDICTING PROSTATE CANCER VOLUME AND ACCOUNTING FOR OVERWEIGHT AND OBESITY RELATED PSA HEMODILUTION

  2016cites this paper
• REGULATION OF CANCER METASTASIS BY PROTEIN KINASE D1: A GLOBAL REGULATORY CASCADE

  2016cites this paper
• QUINAZOLINE + BASED ! ALPHA 1 + ADRENOCEPTOR ! ANTAGONISTS ! AND ! PROSTATE ! CANCER !

  2016cites this paper
• Genetic variants in ATP6 and ND3 mitochondrial genes are not associated with aggressive prostate cancer in Mexican–Mestizo men with overweight or obesity

  2016cites this paper
• Prostate-specific Antigen Mass Density--A Measure Predicting Prostate Cancer Volume and Accounting for Overweight and Obesity-related Prostate-specific Antigen Hemodilution.

  2016cites this paper
• The impact of diabetes and other metabolic disorders on prostate cancer prognosis.

  2016influential citation
• Socioeconomic position and mortality among patients with prostate cancer: influence of mediating factors

  2016cites this paper
• Polymorphisms of eNOS, catalase, and myeloperoxidase genes in prostate cancer in Turkish men: preliminary results.

  2016cites this paper
• Body mass index and mortality in prostate cancer patients: a dose–response meta-analysis

  2016cites this paper
• Childhood height, adult height, and the risk of prostate cancer

  2016cites this paper
• Apolipoproteins, lipids and risk of cancer

  2016cites this paper
• Correlation between body mass index (BMI) and the Gleason score of prostate biopsies in Chinese population

  2016cites this paper
• Association between Body Mass Index and Cancer Survival in a Pooled Analysis of 22 Clinical Trials

  2016cites this paper
• Obesity and prostate cancer-specific mortality after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database

  2016cites this paper
• Linking obesogenic dysregulation to prostate cancer progression

  2015cites this paper
• WOOD BIOCHEMICALS FOR THE PROTECTION OF HEALTH FOCUS ON HEMICELLULOSE, STILBENOIDS AND LIGNANS

  2015cites this paper
• Total, free, and complexed prostate-specific antigen levels among US men, 2007-2010.

  2015cites this paper
• MRS measured fatty acid composition of periprostatic adipose tissue correlates with pathological measures of prostate cancer aggressiveness

  2015cites this paper
• Gene interference strategies as a new tool for the treatment of prostate cancer

  2015cites this paper
• Anthropometric Measures at Multiple Times Throughout Life and Prostate Cancer

  2015cites this paper
• Anthropometric Measures at Multiple Times Throughout Life and Prostate Cancer Diagnosis, Metastasis, and Death.

  2015cites this paper
• Is Irisin an Anticarcinogenic Peptide

  2015cites this paper
• Anthropometric Measures at Multiple Times Throughout Life and Prostate Cancer Diagnosis, Metastasis, and Death.

  2015cites this paper